Gemtuzumab ozogamicin in infants with AML: Results from the Children’s Oncology Group trials AAML03P1 and AAML0531

Erin M. Guest; Richard Aplenc; Lillian Sung; Susana C. Raimondi; Betsy A. Hirsch; Todd A. Alonzo; Robert B. Gerbing; Yi Cheng Jim Wang; Samir B. Kahwash; Amy Heerema-McKenney; Soheil Meshinchi; Alan S. Gamis

doi:10.1182/blood-2017-01-762336

Gemtuzumab ozogamicin in infants with AML: Results from the Children’s Oncology Group trials AAML03P1 and AAML0531

Erin M. Guest, Richard Aplenc, Lillian Sung, Susana C. Raimondi, Betsy A. Hirsch, Todd A. Alonzo, Robert B. Gerbing, Yi Cheng Jim Wang, Samir B. Kahwash, Amy Heerema-McKenney, Soheil Meshinchi, Alan S. Gamis

Laboratory Medicine and Pathology

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Original language	English (US)
Pages (from-to)	943-945
Number of pages	3
Journal	Blood
Volume	130
Issue number	7
DOIs	https://doi.org/10.1182/blood-2017-01-762336
State	Published - Aug 17 2017

Bibliographical note

Funding Information:
Acknowledgments: This study was supported by research funding from the National Institutes of Health, National Cancer Institute under award numbers U10CA180899 (T.A.A., R.B.G., and Y.-C.J.W.), U10CA180886 (R.A., L.S., S.C.R., B.A.H., S.B.K., A.H.-M., S.M., and A.S.G.), and U10CA098543 (R.A., L.S., S.C.R., B.A.H., S.B.K., A.H.-M., S.M., and A.S.G.), and the Andrew McDonough B+ Foundation (Y.-C.J.W.).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1182/blood-2017-01-762336

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561899

OpenUrl availability

Full text

Cite this

Guest, E. M., Aplenc, R., Sung, L., Raimondi, S. C., Hirsch, B. A., Alonzo, T. A., Gerbing, R. B., Wang, Y. C. J., Kahwash, S. B., Heerema-McKenney, A., Meshinchi, S., & Gamis, A. S. (2017). Gemtuzumab ozogamicin in infants with AML: Results from the Children’s Oncology Group trials AAML03P1 and AAML0531. Blood, 130(7), 943-945. https://doi.org/10.1182/blood-2017-01-762336

@article{1c64a085bcd54bdaa1dad116ed7452e6,

title = "Gemtuzumab ozogamicin in infants with AML: Results from the Children{\textquoteright}s Oncology Group trials AAML03P1 and AAML0531",

author = "Guest, {Erin M.} and Richard Aplenc and Lillian Sung and Raimondi, {Susana C.} and Hirsch, {Betsy A.} and Alonzo, {Todd A.} and Gerbing, {Robert B.} and Wang, {Yi Cheng Jim} and Kahwash, {Samir B.} and Amy Heerema-McKenney and Soheil Meshinchi and Gamis, {Alan S.}",

note = "Funding Information: Acknowledgments: This study was supported by research funding from the National Institutes of Health, National Cancer Institute under award numbers U10CA180899 (T.A.A., R.B.G., and Y.-C.J.W.), U10CA180886 (R.A., L.S., S.C.R., B.A.H., S.B.K., A.H.-M., S.M., and A.S.G.), and U10CA098543 (R.A., L.S., S.C.R., B.A.H., S.B.K., A.H.-M., S.M., and A.S.G.), and the Andrew McDonough B+ Foundation (Y.-C.J.W.).",

year = "2017",

month = aug,

day = "17",

doi = "10.1182/blood-2017-01-762336",

language = "English (US)",

volume = "130",

pages = "943--945",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

TY - JOUR

T1 - Gemtuzumab ozogamicin in infants with AML

T2 - Results from the Children’s Oncology Group trials AAML03P1 and AAML0531

AU - Guest, Erin M.

AU - Aplenc, Richard

AU - Sung, Lillian

AU - Raimondi, Susana C.

AU - Hirsch, Betsy A.

AU - Alonzo, Todd A.

AU - Gerbing, Robert B.

AU - Wang, Yi Cheng Jim

AU - Kahwash, Samir B.

AU - Heerema-McKenney, Amy

AU - Meshinchi, Soheil

AU - Gamis, Alan S.

N1 - Funding Information: Acknowledgments: This study was supported by research funding from the National Institutes of Health, National Cancer Institute under award numbers U10CA180899 (T.A.A., R.B.G., and Y.-C.J.W.), U10CA180886 (R.A., L.S., S.C.R., B.A.H., S.B.K., A.H.-M., S.M., and A.S.G.), and U10CA098543 (R.A., L.S., S.C.R., B.A.H., S.B.K., A.H.-M., S.M., and A.S.G.), and the Andrew McDonough B+ Foundation (Y.-C.J.W.).

PY - 2017/8/17

Y1 - 2017/8/17

UR - http://www.scopus.com/inward/record.url?scp=85027859046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027859046&partnerID=8YFLogxK

U2 - 10.1182/blood-2017-01-762336

DO - 10.1182/blood-2017-01-762336

M3 - Letter

C2 - 28674028

AN - SCOPUS:85027859046

SN - 0006-4971

VL - 130

SP - 943

EP - 945

JO - Blood

JF - Blood

IS - 7

ER -

Gemtuzumab ozogamicin in infants with AML: Results from the Children’s Oncology Group trials AAML03P1 and AAML0531

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this